Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Practical guide for the comparison of two next-generation sequencing systems for solid tumour analysis in a universal healthcare system.

Maxwell P, Hynes SO, Fuchs M, Craig S, McGready C, McLean F, McQuaid S, James J, Salto-Tellez M.

J Clin Pathol. 2019 Mar;72(3):225-231. doi: 10.1136/jclinpath-2017-204917. Epub 2018 Jan 31.

PMID:
29386326
2.

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.

Jain S, Lyons CA, Walker SM, McQuaid S, Hynes SO, Mitchell DM, Pang B, Logan GE, McCavigan AM, O'Rourke D, McArt DG, McDade SS, Mills IG, Prise KM, Knight LA, Steele CJ, Medlow PW, Berge V, Katz B, Loblaw DA, Harkin DP, James JA, O'Sullivan JM, Kennedy RD, Waugh DJ.

Ann Oncol. 2018 Jan 1;29(1):215-222. doi: 10.1093/annonc/mdx637.

3.

IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer.

Hutchinson RA, Coleman HG, Gately K, Young V, Nicholson S, Cummins R, Kay E, Hynes SO, Dunne PD, Senevirathne S, Hamilton PW, McArt DG, Longley DB.

Cell Death Discov. 2017 Aug 14;3:17050. doi: 10.1038/cddiscovery.2017.50. eCollection 2017.

4.

Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?

Foley NM, Coll JM, Lowery AJ, Hynes SO, Kerin MJ, Sheehan M, Brodie C, Sweeney KJ.

Pathol Oncol Res. 2018 Oct;24(4):881-884. doi: 10.1007/s12253-017-0304-5. Epub 2017 Sep 11.

PMID:
28891017
5.

Response to Park et al. reply to 'Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study'.

Hynes SO, Coleman HG, Kelly PJ, Dunne PD, Salto-Tellez M, Loughrey MB.

Histopathology. 2017 Aug;71(2):327-329. doi: 10.1111/his.13221. Epub 2017 May 19. No abstract available.

PMID:
28332733
6.

Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study.

Hynes SO, Coleman HG, Kelly PJ, Irwin S, O'Neill RF, Gray RT, McGready C, Dunne PD, McQuaid S, James JA, Salto-Tellez M, Loughrey MB.

Histopathology. 2017 Jul;71(1):12-26. doi: 10.1111/his.13181. Epub 2017 Apr 3.

PMID:
28165633
7.

Tissue-based next generation sequencing: application in a universal healthcare system.

Hynes SO, Pang B, James JA, Maxwell P, Salto-Tellez M.

Br J Cancer. 2017 Feb 28;116(5):553-560. doi: 10.1038/bjc.2016.452. Epub 2017 Jan 19. Review.

8.

Liposomal surface coatings of metal stents for efficient non-viral gene delivery to the injured vasculature.

Ganly S, Hynes SO, Sharif F, Aied A, Barron V, McCullagh K, McMahon J, McHugh P, Crowley J, Wang W, O'Brien T, Greiser U.

J Control Release. 2013 Apr 28;167(2):109-19. doi: 10.1016/j.jconrel.2013.01.036. Epub 2013 Feb 10.

PMID:
23403396
9.

Recurrent dedifferentiated paratesticular liposarcoma with synchronous renal cell carcinoma and prostate cancer.

Coyle D, Flaherty RA, Kelly BD, Hynes SO, Colesky F, Quinlan MR, Corcoran MO, Rogers E.

Curr Urol. 2013 Feb;6(4):216-8. doi: 10.1159/000343543. Epub 2013 Feb 8.

10.

Through the looking glass: primary epithelioid angiosarcoma in the left atrium, a unique site for a rare malignancy.

Hynes SO, Attah CB, Ingoldsby H, Kolcow W, Macneill B, Veerasingam D, Orosz Z.

APMIS. 2013 Jul;121(7):664-7. doi: 10.1111/apm.12036. Epub 2013 Jan 18.

PMID:
23331275
11.

Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury.

Riegler J, Liew A, Hynes SO, Ortega D, O'Brien T, Day RM, Richards T, Sharif F, Pankhurst QA, Lythgoe MF.

Biomaterials. 2013 Mar;34(8):1987-94. doi: 10.1016/j.biomaterials.2012.11.040. Epub 2012 Dec 11.

PMID:
23237516
12.

A unique cause of a rare disorder, unilateral macromastia due to lymphangiomatosis of the breast: a case report.

Hynes SO, McLaughlin R, Kerin M, Rowaiye B, Connolly CE.

Breast J. 2012 Jul-Aug;18(4):367-70. doi: 10.1111/j.1524-4741.2012.01256.x. Epub 2012 Jun 26.

PMID:
22730958
13.

A role for MRP8 in in stent restenosis in diabetes.

Stocca A, O'Toole D, Hynes N, Hynes SO, Mashayekhi K, McGinley L, O'Connell E, Coleman C, Sultan S, Duffy A, Tunev S, O'Brien T.

Atherosclerosis. 2012 Apr;221(2):325-32. doi: 10.1016/j.atherosclerosis.2012.01.036. Epub 2012 Feb 1.

PMID:
22381691
14.

Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.

Sharif F, Hynes SO, McCullagh KJ, Ganley S, Greiser U, McHugh P, Crowley J, Barry F, O'Brien T.

Gene Ther. 2012 Mar;19(3):321-8. doi: 10.1038/gt.2011.92. Epub 2011 Jun 30.

PMID:
21716298
15.

Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy.

Healy NA, Hynes SO, Bruzzi J, Curran S, O'Leary M, Sweeney KJ.

Case Rep Obstet Gynecol. 2011;2011:402127. doi: 10.1155/2011/402127. Epub 2011 Dec 11.

16.

β cell protection by inhibition of iNOS through lentiviral vector-based strategies.

Hynes SO, McCabe C, O'Brien T.

Methods Mol Biol. 2011;704:153-68. doi: 10.1007/978-1-61737-964-2_12.

PMID:
21161636
17.

Bolus delivery of mesenchymal stem cells to injured vasculature in the rabbit carotid artery produces a dysfunctional endothelium.

O'Shea CA, Hynes SO, Shaw G, Coen BA, Hynes AC, McMahon J, Murphy M, Barry F, O'Brien T.

Tissue Eng Part A. 2010 May;16(5):1657-65. doi: 10.1089/ten.TEA.2009.0468.

PMID:
20001215
18.

Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis.

Sharif F, Hynes SO, Cooney R, Howard L, McMahon J, Daly K, Crowley J, Barry F, O'Brien T.

Mol Ther. 2008 Oct;16(10):1674-80. doi: 10.1038/mt.2008.165. Epub 2008 Aug 19.

19.

Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.

Sen S, Conroy S, Hynes SO, McMahon J, O'Doherty A, Bartlett JS, Akhtar Y, Adegbola T, Connolly CE, Sultan S, Barry F, Katusic ZS, O'Brien T.

J Gene Med. 2008 Feb;10(2):143-51.

PMID:
18067196
20.

Cardiovascular gene therapy: current status and therapeutic potential.

Gaffney MM, Hynes SO, Barry F, O'Brien T.

Br J Pharmacol. 2007 Sep;152(2):175-88. Epub 2007 Jun 11. Review.

21.

Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury.

Cooney R, Hynes SO, Sharif F, Howard L, O'Brien T.

Gene Ther. 2007 Mar;14(5):396-404. Epub 2006 Nov 2.

PMID:
17080182
22.

Adenoviral-mediated gene transfer of nitric oxide synthase isoforms and vascular cell proliferation.

Cooney R, Hynes SO, Duffy AM, Sharif F, O'Brien T.

J Vasc Res. 2006;43(5):462-72. Epub 2006 Aug 17.

PMID:
16921253
23.

Gene-eluting stents: comparison of adenoviral and adeno- associated viral gene delivery to the blood vessel wall in vivo.

Sharif F, Hynes SO, McMahon J, Cooney R, Conroy S, Dockery P, Duffy G, Daly K, Crowley J, Bartlett JS, O'Brien T.

Hum Gene Ther. 2006 Jul;17(7):741-50.

PMID:
16839273
24.

Lewis epitopes on outer membrane vesicles of relevance to Helicobacter pylori pathogenesis.

Hynes SO, Keenan JI, Ferris JA, Annuk H, Moran AP.

Helicobacter. 2005 Apr;10(2):146-56.

PMID:
15810946
25.

Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

Kruszewska D, Sahl HG, Bierbaum G, Pag U, Hynes SO, Ljungh A.

J Antimicrob Chemother. 2004 Sep;54(3):648-53. Epub 2004 Jul 28.

PMID:
15282239
26.

Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters.

Hynes SO, Ferris JA, Szponar B, Wadström T, Fox JG, O'Rourke J, Larsson L, Yaquian E, Ljungh A, Clyne M, Andersen LP, Moran AP.

Helicobacter. 2004 Aug;9(4):313-23.

PMID:
15270745
27.

Effect of the antibacterial activity of pig pancreatic juice on human multiresistant bacteria.

Kruszewska D, Ljungh A, Hynes SO, Pierzynowski SG.

Pancreas. 2004 Mar;28(2):191-9.

PMID:
15028952
28.

In vivo expression and function of recombinant GTPCH I in the rabbit carotid artery.

Hynes SO, Smith LA, Richardson DM, Kovesdi I, O'Brien T, Katusic ZS.

Am J Physiol Heart Circ Physiol. 2004 Feb;286(2):H570-4. Epub 2003 Oct 9.

29.

Potential for proteomic profiling of Helicobacter pylori and other Helicobacter spp. using a ProteinChip array.

Hynes SO, McGuire J, Wadström T.

FEMS Immunol Med Microbiol. 2003 May 25;36(3):151-8.

30.

Glycoconjugate binding of gastric and enterohepatic Helicobacter spp.

Hynes SO, Teneberg S, Roche N, Wadström T.

Infect Immun. 2003 May;71(5):2976-80.

32.

Influence of activated charcoal, porcine gastric mucin and beta-cyclodextrin on the morphology and growth of intestinal and gastric Helicobacter spp.

Taneera J, Moran AP, Hynes SO, Nilsson HO, Al-Soud WA, Wadström T.

Microbiology. 2002 Mar;148(Pt 3):677-684. doi: 10.1099/00221287-148-3-677.

PMID:
11882701
33.

Lectin typing of Campylobacter concisus.

Aabenhus R, Hynes SO, Permin H, Moran AP, Andersen LP.

J Clin Microbiol. 2002 Feb;40(2):715-7.

34.

Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing.

Hynes SO, Broutet N, Wadström T, Mikelsaar M, O'Toole PW, Telford J, Engstrand L, Kamiya S, Mentis AF, Moran AP; Eurohepygast Study Group.

J Clin Microbiol. 2002 Jan;40(1):227-32.

35.

Characterisation and differentiation of lactobacilli by lectin typing.

Annuk H, Hynes SO, Hirmo S, Mikelsaar M, Wadström T.

J Med Microbiol. 2001 Dec;50(12):1069-74.

PMID:
11761191
37.

Structure of a D-glycero -D-manno-heptan from the lipopolysaccharide of Helicobacter pylori.

Senchenkova SN, Zatonsky GV, Hynes SO, Widmalm G, Andersen LP, Knirel YA, Jansson PE, Moran AP.

Carbohydr Res. 2001 Mar 22;331(2):219-24.

PMID:
11322737
38.

The relationship between O-chain expression and colonisation ability of Helicobacter pylori in a mouse model.

Moran AP, Sturegård E, Sjunnesson H, Wadström T, Hynes SO.

FEMS Immunol Med Microbiol. 2000 Dec;29(4):263-70.

39.
40.

Genotyping of cagA and vacA, Lewis antigen status, and analysis of the poly-(C) tract in the alpha(1,3)-fucosyltransferase gene of Irish Helicobacter pylori isolates.

Ryan KA, Moran AP, Hynes SO, Smith T, Hyde D, O'Morain CA, Maher M.

FEMS Immunol Med Microbiol. 2000 Jun;28(2):113-20.

41.
42.

Structural studies on lipopolysaccharides of serologically non-typable strains of Helicobacter pylori, AF1 and 007, expressing Lewis antigenic determinants.

Knirel YA, Kocharova NA, Hynes SO, Widmalm G, Andersen LP, Jansson PE, Moran AP.

Eur J Biochem. 1999 Nov;266(1):123-31.

43.

Lack of a relationship between Lewis antigen expression and cagA, CagA, vacA and VacA status of Irish Helicobacter pylori isolates.

Marshall DG, Hynes SO, Coleman DC, O'Morain CA, Smyth CJ, Moran AP.

FEMS Immunol Med Microbiol. 1999 May;24(1):79-90.

44.
45.

Mimicry of blood group antigen A by Helicobacter mustelae and H. pylori.

Moran AP, Hynes SO, Heneghan MA.

Gastroenterology. 1999 Feb;116(2):504-5. No abstract available.

PMID:
9922339
46.

Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms.

Monteiro MA, Chan KH, Rasko DA, Taylor DE, Zheng PY, Appelmelk BJ, Wirth HP, Yang M, Blaser MJ, Hynes SO, Moran AP, Perry MB.

J Biol Chem. 1998 May 8;273(19):11533-43.

Supplemental Content

Loading ...
Support Center